Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 905
Quick answer
905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7709625
Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
granted -
US 7709517
Diarylhydantoin compounds
granted -
US 7709643
Synthesis of sodium narcistatin and related compounds
granted -
US 7709493
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
granted -
US 7709515
Compositions comprising ether compounds and pharmaceutical uses therefor
granted -
US 7709252
Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
granted -
US 7709443
Cyclic peptide antitumor agents
granted -
US 7709257
Models for vaccine assessment
granted -
US 7709456
Modulation of gene expression by oligomers targeted to chromosomal DNA
granted -
US 7708987
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
granted -
US 7709007
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
granted -
US 7709002
Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes
granted -
US 7709609
Tumor suppressor gene, p47ING3
granted -
US 7713710
Isolation and use of solid tumor stem cells
granted -
US 7713939
Illudin analogs useful as antitumor agents
granted -
US 7713973
Kinase inhibitors
granted -
US 7714088
Poly(ethylene glycol) derivatives with proximal reactive groups
granted -
US 7714137
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
granted -
US 7714114
Conjugates of an EPO moiety and a polymer
granted -
US 7714109
Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
granted -
US 7713995
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 7714014
Targeting GLI proteins in human cancer by small molecules
granted -
US 7714009
Nitrogen-containing fused heterocyclic compounds
granted -
US 7713987
Pyrimidine-2,4-diamines and their uses
granted -
US 7713983
Quinazolines useful as modulators of ion channels
granted -
US 7713934
Thrombin peptide derivatives
granted -
US 7713931
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7713927
Antimicrobial peptides
granted -
US 7713925
Syndecans and angiogenesis
granted -
US 7713721
Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
granted -
US 7713526
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
granted -
US 7713529
Methods for treating and preventing infectious disease
granted -
US 7714007
Method of alleviating chronic pain via peripheral glutaminase regulation
granted -
CA 2742910
THERAPIE DE COMBINAISON COMPRENANT UN INHIBITEUR DE DHODH ET DU METHOTREXATE POUR TRAITER UNE MALADIE AUTO-IMMUNE
granted -
US 7718779
Prophylactic and therapeutic monoclonal antibodies
granted -
US 7718629
Compositions and methods for inhibiting expression of Eg5 gene
granted -
US 7718798
Indole compound
granted -
US 7718684
Methods and materials for assessing prostate cancer therapies and compounds
granted -
US 7718781
Hydroxypyridonate and hydroxypyrimidinone chelating agents
granted -
US 7718618
Human cathelicidin antimicrobial peptides
granted -
US 7718658
Quinazolines useful as modulators of ion channels
granted -
US 7718612
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 7718600
IAP binding compounds
granted -
US 7718428
Myeloid colony stimulating factor and uses thereof
granted -
US 7718424
AAV4 vector and uses thereof
granted -
US 7718386
Methods for the diagnosis of diabetes
granted -
US 7718183
Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species
granted -
US 7718170
Alkaline phosphatase compositions to reduce skin cancer
granted
Frequently asked questions
How many pharma patents expire in 2030?
905 published patents in our USPTO index have expiration dates falling in calendar year 2030.